Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Sting-Eze is an over-the-counter topical small-molecule combination product for symptomatic relief of pain, itching, burning, and swelling associated with insect bites and stings. The product is manufactured and distributed by Wisconsin Pharmacal and contains benzocaine, phenol, and camphor as active ingredients. Its activity is primarily local and symptomatic rather than pathway-targeted: benzocaine provides topical local anesthetic activity, phenol contributes antiseptic and local anesthetic effects, and camphor provides topical antipruritic and counterirritant relief. It is used for bites and stings from insects such as mosquitoes, bees, wasps, hornets, ants, fire ants, and ticks, and is marketed as a nonprescription topical liquid under OTC drug regulations.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Sting-Eze.